These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 24573075)

  • 41. High sacrectomy for locally recurrent rectal cancer: Can long-term survival be achieved?
    Dozois EJ; Privitera A; Holubar SD; Aldrete JF; Sim FH; Rose PS; Walsh MF; Bower TC; Leibovich BC; Nelson H; Larson DW
    J Surg Oncol; 2011 Feb; 103(2):105-9. PubMed ID: 21259242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Posterior high sacral segmental disconnection prior to anterior en bloc exenteration for recurrent rectal cancer.
    Brown KGM; Solomon MJ; Austin KKS; Lee PJ; Stalley P
    Tech Coloproctol; 2016 Jun; 20(6):401-404. PubMed ID: 27000857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Robotic coloanal anastomosis with or without intersphincteric resection for low rectal cancer: starting with the perianal approach followed by robotic procedure.
    Kang J; Hur H; Min BS; Lee KY; Kim NK
    Ann Surg Oncol; 2012 Jan; 19(1):154-5. PubMed ID: 21822556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Robotic-assisted surgery for rectal adenocarcinoma: short-term and midterm outcomes from 200 consecutive cases at a single institution.
    Hara M; Sng K; Yoo BE; Shin JW; Lee DW; Kim SH
    Dis Colon Rectum; 2014 May; 57(5):570-7. PubMed ID: 24819096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Results of resection of locally recurrent rectal cancer].
    Billiet C; Berard P; Rivoalan F; Neyra P; Gouillat C
    Ann Chir; 2006 Dec; 131(10):601-7. PubMed ID: 17010929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early and Late Outcomes of Surgery for Locally Recurrent Rectal Cancer: A Prospective 10-Year Study in the Total Mesorectal Excision Era.
    Nielsen M; Rasmussen P; Pedersen B; Hagemann-Madsen R; Lindegaard J; Laurberg S
    Ann Surg Oncol; 2015 Aug; 22(8):2677-84. PubMed ID: 25564165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How Does the Level of Sacral Resection for Primary Malignant Bone Tumors Affect Physical and Mental Health, Pain, Mobility, Incontinence, and Sexual Function?
    Phukan R; Herzog T; Boland PJ; Healey J; Rose P; Sim FH; Yazsemski M; Hess K; Osler P; DeLaney TF; Chen YL; Hornicek F; Schwab J
    Clin Orthop Relat Res; 2016 Mar; 474(3):687-96. PubMed ID: 26013155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent.
    Bird TG; Ngan SY; Chu J; Kroon R; Lynch AC; Heriot AG
    Int J Colorectal Dis; 2018 Apr; 33(4):393-401. PubMed ID: 29468354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncologic and functional outcome following sacrectomy for sacral chordoma.
    Hulen CA; Temple HT; Fox WP; Sama AA; Green BA; Eismont FJ
    J Bone Joint Surg Am; 2006 Jul; 88(7):1532-9. PubMed ID: 16818979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving Surgical Outcomes in Pelvic Exenteration Surgery: Comparison of Prone Sacrectomy With Anterior Cortical Sacrectomy Techniques.
    van Kessel CS; Waller J; Steffens D; Lee PJ; Austin KKS; Stalley PD; Solomon MJ
    Ann Surg; 2023 Dec; 278(6):945-953. PubMed ID: 37485983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in surgical management for locally recurrent rectal cancer: How far have we come?
    Lee DJ; Sagar PM; Sadadcharam G; Tan KY
    World J Gastroenterol; 2017 Jun; 23(23):4170-4180. PubMed ID: 28694657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Residual neurological function after sacral root resection during en-bloc sacrectomy: a systematic review.
    Zoccali C; Skoch J; Patel AS; Walter CM; Maykowski P; Baaj AA
    Eur Spine J; 2016 Dec; 25(12):3925-3931. PubMed ID: 26914097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abdominal sacral resection of locally recurrent rectal cancer.
    Wanebo HJ; Marcove RC
    Ann Surg; 1981 Oct; 194(4):458-71. PubMed ID: 7283507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. One-staged subtotal sacrectomy for primary sacral tumor.
    Sahakitrungruang C; Chantra K
    Ann Surg Oncol; 2009 Sep; 16(9):2594. PubMed ID: 19565287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Laparoscopic surgery for stage 0/I rectal carcinoma: short-term outcomes of a single-arm phase II trial.
    Yamamoto S; Ito M; Okuda J; Fujii S; Yamaguchi S; Yoshimura K; Sugihara K; Watanabe M;
    Ann Surg; 2013 Aug; 258(2):283-8. PubMed ID: 23426337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postoperative pain management after concomitant sacrectomy for locally recurrent rectal cancer.
    Kitakaze M; Uemura M; Kobayashi Y; Paku M; Miyo M; Takahashi Y; Miyake M; Kato T; Ikeda M; Fujino S; Ogino T; Miyoshi N; Takahashi H; Yamamoto H; Mizushima T; Sekimoto M; Doki Y; Eguchi H
    Surg Today; 2022 Nov; 52(11):1599-1606. PubMed ID: 35661260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sacrectomy for primary sacral tumors.
    Sahakitrungruang C; Chantra K; Dusitanond N; Atittharnsakul P; Rojanasakul A
    Dis Colon Rectum; 2009 May; 52(5):913-8. PubMed ID: 19502856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome after curative resection for locally recurrent rectal cancer.
    Bedrosian I; Giacco G; Pederson L; Rodriguez-Bigas MA; Feig B; Hunt KK; Ellis L; Curley SA; Vauthey JN; Delclos M; Crane CH; Janjan N; Skibber JM
    Dis Colon Rectum; 2006 Feb; 49(2):175-82. PubMed ID: 16392024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors associated with oncologic outcomes after abdominoperineal resection compared with restorative resection for low rectal cancer: patient- and tumor-related or technical factors only?
    Reshef A; Lavery I; Kiran RP
    Dis Colon Rectum; 2012 Jan; 55(1):51-8. PubMed ID: 22156867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
    Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
    BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.